rs1046565
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_002866.5(RAB3A):āc.285T>Cā(p.Ala95Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.306 in 1,613,350 control chromosomes in the GnomAD database, including 81,309 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.25 ( 6190 hom., cov: 32)
Exomes š: 0.31 ( 75119 hom. )
Consequence
RAB3A
NM_002866.5 synonymous
NM_002866.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.23
Genes affected
RAB3A (HGNC:9777): (RAB3A, member RAS oncogene family) Enables GTPase activity and myosin V binding activity. Involved in several processes, including acrosomal vesicle exocytosis; lysosome localization; and plasma membrane repair. Located in perinuclear region of cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 19-18200389-A-G is Benign according to our data. Variant chr19-18200389-A-G is described in ClinVar as [Benign]. Clinvar id is 1335855.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.23 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.341 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAB3A | NM_002866.5 | c.285T>C | p.Ala95Ala | synonymous_variant | 3/5 | ENST00000222256.9 | NP_002857.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAB3A | ENST00000222256.9 | c.285T>C | p.Ala95Ala | synonymous_variant | 3/5 | 1 | NM_002866.5 | ENSP00000222256.3 | ||
RAB3A | ENST00000481914.2 | c.285T>C | p.Ala95Ala | synonymous_variant | 3/3 | 3 | ENSP00000472335.1 | |||
RAB3A | ENST00000464076.3 | c.-1T>C | 5_prime_UTR_variant | 2/4 | 2 | ENSP00000474603.1 |
Frequencies
GnomAD3 genomes AF: 0.253 AC: 38464AN: 151996Hom.: 6189 Cov.: 32
GnomAD3 genomes
AF:
AC:
38464
AN:
151996
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.283 AC: 70967AN: 251108Hom.: 11616 AF XY: 0.282 AC XY: 38296AN XY: 135712
GnomAD3 exomes
AF:
AC:
70967
AN:
251108
Hom.:
AF XY:
AC XY:
38296
AN XY:
135712
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.312 AC: 455802AN: 1461236Hom.: 75119 Cov.: 35 AF XY: 0.309 AC XY: 224400AN XY: 726922
GnomAD4 exome
AF:
AC:
455802
AN:
1461236
Hom.:
Cov.:
35
AF XY:
AC XY:
224400
AN XY:
726922
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.253 AC: 38470AN: 152114Hom.: 6190 Cov.: 32 AF XY: 0.254 AC XY: 18896AN XY: 74356
GnomAD4 genome
AF:
AC:
38470
AN:
152114
Hom.:
Cov.:
32
AF XY:
AC XY:
18896
AN XY:
74356
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
489
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 19, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at